Search research articles
Contact Us
Filters
Showing results (231-240 of 279) with videos related to
Page
of 28
Sort By:
BJU International
|
September 24, 2013
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy
Jacob T Ark, Kirk A Keegan, Daniel A Barocas, et al.
European Urology Oncology
|
June 19, 2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
Wei Shen Tan, Gary Steinberg, J Alfred Witjes, et al.
The New England Journal of Medicine
|
May 30, 2020
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
Neal D Shore, Fred Saad, Michael S Cookson, et al.
The Journal of Urology
|
August 21, 2010
Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence
Shady Salem, Sam S Chang, Peter E Clark, et al.
The Journal of Urology
|
June 15, 2014
Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy
Chad R Ritch, Michael S Cookson, Sam S Chang, et al.
The Canadian Journal of Urology
|
April 18, 2016
Short term complications from transurethral resection of bladder tumor
Justin R Gregg, Benjamin McCormick, Li Wang, et al.
Urologic Oncology
|
September 24, 2013
Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device
Ian M Thompson, Stephen F Kappa, Todd M Morgan, et al.
European Urology Oncology
|
May 19, 2019
Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review
Yair Lotan, Peter C Black, Laura Caba, et al.
The Journal of Urology
|
July 21, 2010
Smaller prostate size predicts high grade prostate cancer at final pathology
Mark R Newton, Sharon Phillips, Sam S Chang, et al.
The Prostate
|
March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines
Neal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 279) with videos related to
Sort By:
Page
of 28
BJU International
|
September 24, 2013
Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy
Jacob T Ark, Kirk A Keegan, Daniel A Barocas, et al.
European Urology Oncology
|
June 19, 2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
Wei Shen Tan, Gary Steinberg, J Alfred Witjes, et al.
The New England Journal of Medicine
|
May 30, 2020
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
Neal D Shore, Fred Saad, Michael S Cookson, et al.
The Journal of Urology
|
August 21, 2010
Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence
Shady Salem, Sam S Chang, Peter E Clark, et al.
The Journal of Urology
|
June 15, 2014
Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy
Chad R Ritch, Michael S Cookson, Sam S Chang, et al.
The Canadian Journal of Urology
|
April 18, 2016
Short term complications from transurethral resection of bladder tumor
Justin R Gregg, Benjamin McCormick, Li Wang, et al.
Urologic Oncology
|
September 24, 2013
Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device
Ian M Thompson, Stephen F Kappa, Todd M Morgan, et al.
European Urology Oncology
|
May 19, 2019
Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review
Yair Lotan, Peter C Black, Laura Caba, et al.
The Journal of Urology
|
July 21, 2010
Smaller prostate size predicts high grade prostate cancer at final pathology
Mark R Newton, Sharon Phillips, Sam S Chang, et al.
The Prostate
|
March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines
Neal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
Page
of 28